Cargando…

Inhibition of Elongation Factor-2 Kinase Augments the Antitumor Activity of Temozolomide against Glioma

BACKGROUND: Glioblastoma multiforme (GBM), the most common form of brain cancer with an average survival of less than 12 months, is a highly aggressive and fatal disease characterized by survival of glioma cells following initial treatment, invasion through the brain parenchyma and destruction of no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiao-yuan, Zhang, Li, Wu, JianPing, Zhou, Lei, Ren, Yi-Jie, Yang, Wei-Qiong, Ming, Zi-Jun, Chen, Bo, Wang, Jianrong, Zhang, Yi, Yang, Jin-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841121/ https://www.ncbi.nlm.nih.gov/pubmed/24303044 http://dx.doi.org/10.1371/journal.pone.0081345

Ejemplares similares

Antitumor effect of fibrin glue containing temozolomide against malignant glioma
por: Anai, Shigeo, et al.
Publicado: (2014)

Apatinib suppresses cell growth and metastasis and promotes antitumor activity of temozolomide in glioma
por: Wang, Chao, et al.
Publicado: (2018)

Elongation factor-2 kinase is a critical determinant of the fate and antitumor immunity of CD8(+) T cells
por: Das, Jugal Kishore, et al.
Publicado: (2022)

The strategy for enhancing temozolomide against malignant glioma
por: Nakada, Mitsutoshi, et al.
Publicado: (2012)

Inhibition of Mitochondria- and Endoplasmic Reticulum Stress-Mediated Autophagy Augments Temozolomide-Induced Apoptosis in Glioma Cells
por: Lin, Chien-Ju, et al.
Publicado: (2012)

Rational Incorporation of Selenium into Temozolomide Elicits Superior Antitumor Activity Associated with Both Apoptotic and Autophagic Cell Death
por: Cheng, Yan, et al.
Publicado: (2012)

Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010)

Exosomal connexin 43 regulates the resistance of glioma cells to temozolomide
por: Yang, Zhang-Jian, et al.
Publicado: (2021)

Piperine synergistically enhances the effect of temozolomide against temozolomide-resistant human glioma cell lines
por: Jeong, Somi, et al.
Publicado: (2020)

β-elemene combined with temozolomide in treatment of brain glioma
por: Zhang, Xiaomin, et al.
Publicado: (2021)

Temozolomide and chloroquine co-loaded mesoporous silica nanoparticles are effective against glioma
por: Zhang, Peng, et al.
Publicado: (2023)

IL-24 Induces Apoptosis via Upregulation of RNA-Activated Protein Kinase and Enhances Temozolomide-Induced Apoptosis in Glioma Cells
por: Hu, Chang-Wei, et al.
Publicado: (2015)

The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells
por: Xu, Yuanyuan, et al.
Publicado: (2016)

Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2
por: Zhang, Xin, et al.
Publicado: (2018)

Paeoniflorin exerts antitumor effects by inactivating S phase kinase-associated protein 2 in glioma cells
por: Ouyang, Jia, et al.
Publicado: (2018)

Treating malignant glioma in Chinese patients: update on temozolomide
por: Chang, Liang, et al.
Publicado: (2014)

Temozolomide Chemotherapy in Patients with Recurrent Malignant Gliomas
por: Yang, Seung-Ho, et al.
Publicado: (2006)

Natural borneol is a novel chemosensitizer that enhances temozolomide-induced anticancer efficiency against human glioma by triggering mitochondrial dysfunction and reactive oxide species-mediated oxidative damage
por: Liu, Wen-Jian, et al.
Publicado: (2018)

Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma
por: Suryadevara, Carter M., et al.
Publicado: (2018)

Differential Characterization of Temozolomide-Resistant Human Glioma Cells
por: Lai, Sheng-Wei, et al.
Publicado: (2018)

Valproic acid-induced amphiregulin secretion confers resistance to temozolomide treatment in human glioma cells
por: Chen, Jui-Chieh, et al.
Publicado: (2019)

Cinnamophilin enhances temozolomide-induced cytotoxicity against malignant glioma: the roles of ROS and cell cycle arrest
por: Tai, Shih-Hang, et al.
Publicado: (2021)

Combination therapy with F5/35 fiber chimeric conditionally replicative adenoviruses expressing IL‐24 enhances the antitumor effect of temozolomide against melanoma
por: Yang, Ming, et al.
Publicado: (2018)

Low c-Met expression levels are prognostic for and predict the benefits of temozolomide chemotherapy in malignant gliomas
por: Li, Ming-Yang, et al.
Publicado: (2016)

A Potential Mechanism of Temozolomide Resistance in Glioma–Ferroptosis
por: Hu, Zhifang, et al.
Publicado: (2020)

Insights Into the Pathologic Roles and Regulation of Eukaryotic Elongation Factor-2 Kinase
por: Ballard, Darby J., et al.
Publicado: (2021)

Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas
por: Ulasov, Ilya, et al.
Publicado: (2013)

Radiation combined with temozolomide contraindicated for young adults diagnosed with anaplastic glioma
por: Yang, Pei, et al.
Publicado: (2016)

Inhibition of DNA Repair in Combination with Temozolomide or Dianhydrogalactiol Overcomes Temozolomide-Resistant Glioma Cells
por: Ohba, Shigeo, et al.
Publicado: (2021)

Lomustine and nimustine exert efficient antitumor effects against glioblastoma models with acquired temozolomide resistance
por: Yamamuro, Shun, et al.
Publicado: (2021)

Targeting autophagy to sensitive glioma to temozolomide treatment
por: Yan, Yuanliang, et al.
Publicado: (2016)

Glioma and temozolomide induced alterations in gut microbiome
por: Patrizz, Anthony, et al.
Publicado: (2020)

Temozolomide Chronotherapy in Glioma: A Systematic Review
por: Jia, Jason L., et al.
Publicado: (2023)

Effect of temozolomide on livin and caspase-3 in U251 glioma stem cells
por: LI, GENHUA, et al.
Publicado: (2015)

Silver nanoparticles enhance the sensitivity of temozolomide on human glioma cells
por: Liang, Ping, et al.
Publicado: (2016)

SU4312 Represses Glioma Progression by Inhibiting YAP and Inducing Sensitization to the Effect of Temozolomide
por: Wang, Xu, et al.
Publicado: (2022)

Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells
por: Qiu, Zhi-Kun, et al.
Publicado: (2014)

The nanoprodrug of polytemozolomide combines with MGMT siRNA to enhance the effect of temozolomide in glioma
por: Xu, Haoyue, et al.
Publicado: (2022)

Aspirin inhibits the SHH/GLI1 signaling pathway and sensitizes malignant glioma cells to temozolomide therapy
por: Ming, Jianguang, et al.
Publicado: (2017)

Drug metabolism-related gene ABCA1 augments temozolomide chemoresistance and immune infiltration abundance of M2 macrophages in glioma
por: Yan, Yuanliang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7emfjtbani43ljdcstlb003mj6